WUXI BIO (02269) has issued a total of 2,423,900 shares under the pre-IPO stock option plan.
WuXi Biologics (02269) announced that on September 3, 2026, it will issue a total of 2,423,900 ordinary shares to exercise options under the pre-IPO share option scheme adopted by the company on January 5, 2016, which was amended on August 10, 2016.
WUXI BIO (02269) announced that on September 3, 2026, it will issue a total of 2,423,900 ordinary shares in order to exercise options under the pre-IPO share option plan adopted by the company on January 5, 2016 (revised on August 10, 2016).
Related Articles
US Stock Market Move | Microsoft Corporation (MSFT.US) rose over 3%, with Azure's annual sales exceeding 100 billion dollars.
US Stock Market Move | Dell Technologies, Inc. Class C shares (DELL.US) rose over 4%, reaching an all-time high.
NEW CONCEPTS (02221) plans to issue approximately 14.8949 million consideration shares at a premium of 78.51% to acquire 70% equity in Anhui Feidian Environmental Technology Co., Ltd.
US Stock Market Move | Microsoft Corporation (MSFT.US) rose over 3%, with Azure's annual sales exceeding 100 billion dollars.
US Stock Market Move | Dell Technologies, Inc. Class C shares (DELL.US) rose over 4%, reaching an all-time high.
NEW CONCEPTS (02221) plans to issue approximately 14.8949 million consideration shares at a premium of 78.51% to acquire 70% equity in Anhui Feidian Environmental Technology Co., Ltd.
RECOMMEND
